Uterine Carcinoma

2

Review clinical trials related to Uterine Carcinoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Azenosertib in Uterine Serous Carcinoma: Biomarker Study

This research study is being done to investigate how Azenosertib affects tumor cells of persistent or recurrent uterine serous carcinoma. The name of the study drug involved in this study is: -Azenosertib (a type of Wee1 inhibitor)

Participants needed: 25
Trial details
Phase: Phase 2Age: 18+Biological sex: FemaleType: InterventionalSponsor: Joyce Liu, MDUpdated: Mar 2, 2026Locations: 2
Eligibility criteria

Participants must have histologically or cytologically confirmed recurrent or pe... [+17]

Participants who have had chemotherapy, radiotherapy, or investigational therapy... [+10]

Status: Not yet recruiting

Clinical Feasibility of the ARCHITECT Applicator in Cervical Cancer Brachytherapy

This prospective, non-randomised, single centre, phase I trial assesses the clinical feasibility of the use of the patient-tailored ARCHITECT applicator in locally advanced cervical cancer brachytherapy.

Participants needed: 25
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: Erasmus Medical CenterUpdated: Feb 27, 2026Locations: 1
Eligibility criteria

Locally advanced cervical cancer (FIGO 2018 stage 1B3-IVA) with indication for p... [+1]

Unable to give informed consent; [+3]